RSS Items

In HIV and ID Observations, Dr. Paul Sax discusses the results of the SCORPIO-HR study.

A new consensus statement from the American Academy of Pediatrics offers evidence-based guidance.

Adverse cardiovascular events were less frequent when colchicine was added to urate-lowering therapy for initial gout treatment.

In HIV and ID Observations, read Dr. Paul Sax's roundup on CROI.

In a phase 2 manufacturer-funded trial, lepodisiran safely reduced Lp(a) levels in a dose-dependent manner.

So far, studies suggest modest benefits for acute postoperative pain, but many questions remain.

Delaying initiation of RRT for as long as 96 hours was not associated with excess mortality among patients in the ICU.

Dr. Paul Sax reflects on two ID meetings — one defunct and one thriving — in HIV and ID Observations.

Dr. Paul Sax discusses the largest randomized, controlled trial ever conducted for Staphylococcus aureus bacteremia in HIV and ID Observations.

This guideline provides recommendations on the indication and thresholds for transfusion.